首页> Journal of controlled release : official journal of the Controlled Release Society> Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo.

Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo.

导出 LinkOut

翻译打印收藏纠错

第一作者： Arong,Gaowa

第一单位： Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.

作者： Arong,Gaowa ^[1] ; Tomohisa,Horibe ^[1] ; Masayuki,Kohno ^[1] ; Keisuke,Sato ^[2] ; Hiroshi,Harada ^[3] ; Masahiro,Hiraoka ^[3] ; Yasuhiko,Tabata ^[2] ; Koji,Kawakami ^[4]

作者单位： Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. ^[1] Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan. ^[2] Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan. ^[3] Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. Electronic address: kawakami.koji.4e@kyoto-u.ac.jp. ^[4]

关键词 Anti-tumor activity Controlled release DDS Gelatin hydrogel Hybrid peptide Pharmacokinetics